Show simple item record

dc.contributor.authorTran, Hoang V.
dc.contributor.authorGore, Joel M.
dc.contributor.authorDarling, Chad E.
dc.contributor.authorAsh, Arlene S.
dc.contributor.authorKiefe, Catarina I.
dc.contributor.authorGoldberg, Robert J.
dc.date2022-08-11T08:08:17.000
dc.date.accessioned2022-08-23T15:49:36Z
dc.date.available2022-08-23T15:49:36Z
dc.date.issued2018-10-19
dc.date.submitted2018-12-05
dc.identifier.citation<p>J Psychosom Res. 2018 Oct 19. pii: S0022-3999(18)30598-1. doi: 10.1016/j.jpsychores.2018.10.008. [Epub ahead of print] <a href="https://doi.org/10.1016/j.jpsychores.2018.10.008">Link to article on publisher's site</a></p>
dc.identifier.issn0022-3999 (Linking)
dc.identifier.doi10.1016/j.jpsychores.2018.10.008
dc.identifier.pmid30482494
dc.identifier.urihttp://hdl.handle.net/20.500.14038/28475
dc.description.abstractBACKGROUND: Depression and anxiety are common and associated with worse clinical outcomes in patients who experience an acute coronary syndrome (ACS). We investigated the association between major ventricular arrhythmias (VAs) with the progression of depression and anxiety among hospital survivors of an ACS. METHODS: Patients were interviewed in hospital and by telephone up to 12months after hospital discharge. The primary outcome was the presence of moderate/severe symptoms of depression and anxiety defined as a Patient Health Questionnaire (PHQ)-9 score > /=10 and a Generalized Anxiety Disorder (GAD)-7 score > /=10 at baseline and 1 month and PHQ-2 > /=3 and GAD-2 > /=3 at 3, 6, and 12 months. We used marginal models to examine the association between major VAs and the symptoms of depression or anxiety over time. RESULTS: The average age of the study population (n=2074) was 61.1years, 33.5% were women, and 78.3% were white. VAs developed in 105 patients (5.1%). Symptoms of depression and anxiety were present in 22.2% and 23.5% of patients at baseline, respectively, and declined to 14.1% and 12.6%, respectively, at 1-month post-discharge. VAs were not significantly associated with the progression of symptoms of depression (adjusted relative risk [aRR]=1.29, 95% confidence interval [CI]=0.94-1.77) and anxiety (aRR=1.22, 95% CI=0.86-1.72), or with change in average scores of PHQ-2 and GAD-2 over time, both before and after risk adjustment. CONCLUSION: The prevalence of symptoms of depression and anxiety was high after an ACS but declined thereafter and may not be associated with the occurrence of major in-hospital VAs.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=30482494&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1016/j.jpsychores.2018.10.008
dc.subjectAcute coronary syndrome
dc.subjectAnxiety
dc.subjectCardiac arrest
dc.subjectDepression
dc.subjectVentricular fibrillation
dc.subjectVentricular tachycardia
dc.subjectCardiology
dc.subjectCardiovascular Diseases
dc.subjectPsychiatry and Psychology
dc.titleClinically significant ventricular arrhythmias and progression of depression and anxiety following an acute coronary syndrome
dc.typeJournal Article
dc.source.journaltitleJournal of psychosomatic research
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1170&amp;context=emed_pp&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/emed_pp/165
dc.identifier.contextkey13424024
refterms.dateFOA2022-08-23T15:49:37Z
html.description.abstract<p>BACKGROUND: Depression and anxiety are common and associated with worse clinical outcomes in patients who experience an acute coronary syndrome (ACS). We investigated the association between major ventricular arrhythmias (VAs) with the progression of depression and anxiety among hospital survivors of an ACS.</p> <p>METHODS: Patients were interviewed in hospital and by telephone up to 12months after hospital discharge. The primary outcome was the presence of moderate/severe symptoms of depression and anxiety defined as a Patient Health Questionnaire (PHQ)-9 score > /=10 and a Generalized Anxiety Disorder (GAD)-7 score > /=10 at baseline and 1 month and PHQ-2 > /=3 and GAD-2 > /=3 at 3, 6, and 12 months. We used marginal models to examine the association between major VAs and the symptoms of depression or anxiety over time.</p> <p>RESULTS: The average age of the study population (n=2074) was 61.1years, 33.5% were women, and 78.3% were white. VAs developed in 105 patients (5.1%). Symptoms of depression and anxiety were present in 22.2% and 23.5% of patients at baseline, respectively, and declined to 14.1% and 12.6%, respectively, at 1-month post-discharge. VAs were not significantly associated with the progression of symptoms of depression (adjusted relative risk [aRR]=1.29, 95% confidence interval [CI]=0.94-1.77) and anxiety (aRR=1.22, 95% CI=0.86-1.72), or with change in average scores of PHQ-2 and GAD-2 over time, both before and after risk adjustment.</p> <p>CONCLUSION: The prevalence of symptoms of depression and anxiety was high after an ACS but declined thereafter and may not be associated with the occurrence of major in-hospital VAs.</p>
dc.identifier.submissionpathemed_pp/165
dc.contributor.departmentDepartment of Emergency Medicine
dc.contributor.departmentDepartment of Medicine, Division of Cardiovascular Medicine
dc.contributor.departmentDepartment of Quantitative Health Sciences


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
1_s2.0_S0022399918305981_main.pdf
Size:
431.7Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record